Home / Letter From The Editor / Nov. 16, 2019

Nov. 16, 2019

Nov 16, 2019

Whenever you look at the slide from the international diabetes center that shows the progression to diabetes, there is always an arrow pointing to the decline in insulin production as resistance increases. Supposedly fixing this problem was the target of the first oral diabetes medication, chlorpropamide, which became available in 1958.

Over the years we have seen this class of drugs increase the occurrence of hypoglycemia, quicken pancreatic burnout, and increase the incidence of cardiovascular disease.


This week Taylor-Eugene Simmons, Florida A&M University, College of Pharmacy & Pharmaceutical Sciences, PharmD Candidate, looked at multiple studies pointing to the current thinking that sulfonylureas should go the way of the Clinitest strips and Reflectance monitors and be retired forever.



We can make a difference!


Dave Joffe